Digital Technologies

In addition to its recently established Precision Health division, Bayer Consumer Health is using artificial intelligence to save time on routine tasks and to manage supply and demand, the firm’s head of digital transformation and IT, Cristina Nitulescu, tells HBW Insight.

Agency approves Hearing Aid Feature app to make compatible Apple AirPods Pro Bluetooth earbuds OTC hearing aids as well as audio streaming devices. Apple says the no-cost app provides a “scientifically validated” hearing test and “clinical-grade” hearing aid capability.

HBW Insight catches up with Kenvue's Manoj Raghunandanan, who recently switched roles from global head of self care & consumer experience organization to area managing director for Northern Europe. "If I was playing tennis in my old role, I'm playing rugby in my new one. It’s a new game with new rules, and there's a lot happening all around you," he explains in this exclusive interview. Having found his feet, Raghunandanan is now pushing forward regionally with the innovation and technology infrastructure that he had a hand in building. 

Bayer Consumer Health continues to invest in “precision health” with a wellness companion app and biological age test supporting its US dietary supplement brand One A Day, which together it hopes will offer consumers an “Age Factor ecosystem” tailored to their specific needs. 

The Artificial Intelligence Council takes over work that three different entities in the US FDA’s drugs center had been performing. The new, centralized entity will develop and promote consistency in AI-related activities and advance innovative uses.

Clue Plus members will have access to 50% off a Headspace subscription for tailored guidance, support and validation to help manage cycle-related stress and improve overall well-being.

Wild.AI women's health and wellness app available on Zepp’s Amazfit Active; WAT Medical’s app helps users lose weight; and firm Cronometer adds feature to answer users’ most frequent question, "How do I track water?"

Amulet announces $5.8 million in series A financing led by HealthX Ventures along with Incite Ventures, AllerFund, Mendota Venture Capital and Great Oaks Venture Capital. Allergy Amulet is for on-the-go testing of food to determine whether allergens are present.

HBW Insight presents a new series profiling regulatory affairs specialists working in or supporting the consumer health and cosmetics industries. In this first installment, we speak to AESGP's Christelle Anquez-Traxler and Oliver Hartmann, senior regulatory science & strategy lead, and regulatory & legal affairs director respectively. 

Bioniq's latest “oversubscribed” funding round will finance the global expansion of its AI-powered personalized supplement offer, the firm says.

Study with 509 subjects conducted in Petros’ preparation of OTC switch application demonstrated 90.6% correct self-selection for participants using its web app technology and DFL and 57.3% correct by subjects using only DFL.

Draft guidance will offer a risk-based framework for accessing the credibility of AI and help ensure that AI models used to answer regulatory questions are sufficiently credible for a particular ‘context of use,’ CDER’s Tala Fakhouri says.

Aspirin is celebrating its 125th anniversary this year. To find out what brand owner Bayer Consumer Health is doing to celebrate this occasion, and what it is doing to take the brand into the next 125 years, HBW Insight chats with the company’s senior vice president, Global Head Allergy, Cough/Cold, Pain and Heart Health, Reese Fitzpatrick, and head of R&D, North America and Therapeutics, Rachel Koontz.

Doctor's Best acquires Viactiv calcium and magnesium brand from Guardion; VitaliyNow is Society Brands’ third 2024 acquisition; and VitaminLab formulation services on CharmHealth.

Andrew Trister, Verily’s chief medical and scientific officer, discusses Verily’s newly launched Lightpath Metabolic solution, featuring GLP-1 prescription, AI and strengthened clinical support. Plus, the Google health tech spinout's plans for the Study Watch, the Alzheimer’s research landscape, and AI development and regulation in a new era of uncertainty.

When it comes to online consumer health product advertising, complying with regulations, ensuring that content is factually correct and being transparent are some of the key principles that companies should adhere to, recommends AESGP in a recently published position paper. 

The AI medtech revolution could be a “huge, missed opportunity” for the EU without an effective and efficient regulatory infrastructure. Answers are needed fast, MedTech Europe’s Oliver Bisazza said during a recent interview.

Leading digital therapeutic maker’s CEO David Benshoof Klein and CMO Shaheen Lakhan discuss outlook on the DTx space, priorities going forward, and what makes Click a standout player in a changing game.

Real-world data and evidence, for example generated by digital consumer health technology like apps and wearables, could provide crucial support for Rx-to-OTC switch applications, argues Sanofi Consumer Healthcare’s Penny Glover at the Association of the European Self-Care Industry's 60th Annual Meeting in Brussels, Belgium. Recent research by Sanofi indicates that regulators are actually already using RWD and RWE in many cases when assessing switch applications, even if they do not call it that. 

The BBB National Programs, Inc.’s Children’s Advertising Review Unit reminds advertisers its Advertising and Privacy Guidelines extend to the use of AI in ads for children and points them to its recent warning that it will ‘strictly enforce’ those guidelines.